Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 19;6(5):53.
doi: 10.3390/jcm6050053.

The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart

Affiliations
Review

The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart

Kate M Herum et al. J Clin Med. .

Abstract

Cardiac fibrosis, the excessive accumulation of extracellular matrix (ECM), remains an unresolved problem in most forms of heart disease. In order to be successful in preventing, attenuating or reversing cardiac fibrosis, it is essential to understand the processes leading to ECM production and accumulation. Cardiac fibroblasts are the main producers of cardiac ECM, and harbor great phenotypic plasticity. They are activated by the disease-associated changes in mechanical properties of the heart, including stretch and increased tissue stiffness. Despite much remaining unknown, an interesting body of evidence exists on how mechanical forces are translated into transcriptional responses important for determination of fibroblast phenotype and production of ECM constituents. Such mechanotransduction can occur at multiple cellular locations including the plasma membrane, cytoskeleton and nucleus. Moreover, the ECM functions as a reservoir of pro-fibrotic signaling molecules that can be released upon mechanical stress. We here review the current status of knowledge of mechanotransduction signaling pathways in cardiac fibroblasts that culminate in pro-fibrotic gene expression.

Keywords: cardiac fibroblast; cytoskeleton; extracellular matrix; fibrosis; integrins; linker of the nucleoskeleton and cytoskeleton; mechanotransduction; myofibroblast; stiffness; syndecan.

PubMed Disclaimer

Conflict of interest statement

ADM is a co-founder of and has an equity interest in Insilicomed, Inc. He serves as a scientific advisor to the company. Some research grants to ADM, including some of those acknowledged here, have been identified for conflict of interest management based on the overall scope of the project and its potential benefit to Insilicomed, Inc. ADM is required to disclose this relationship in publications acknowledging the grant support, however the research subject matter and findings reported do not involve the company in any way and they have no known relationship to the business activities or interests of the company. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. The other authors have no competing interests to declare.

Figures

Figure 1
Figure 1
Cardiac fibroblasts are located in between cardiomyocytes where they ensure the appropriate amount and composition of extracellular matrix (ECM) in the healthy heart. Mechanical stress induces fibrosis during cardiac remodeling, e.g., hypertrophic remodeling. Fibrosis compromises cardiac function, and results from activation of cardiac fibroblasts and transition into a myofibroblast phenotype characterized by excessive production of ECM.
Figure 2
Figure 2
Mechanical forces are translated into biochemical activity by mechanotransduction, which occurs at different cellular sites and by “activation” of the ECM. In cardiac fibroblasts, mechanical stress leads to pro-fibrotic gene expression.
Figure 3
Figure 3
Mechanotransduction signaling pathways in the cardiac fibroblast. Hyaluronic acid (HA), small leucine-rich proteoglycans (SLRPs), latent TGFβ binding protein 1 (LTBP1), transforming growth factor β (TGFβ), TGFβ receptor (TGFβR), integrins (itg), syndecan (syn), transient receptor potential (TRP) channel, toll-like receptor (TLR), focal adhesion kinase (FAK), Yes-associated protein (YAP), transcriptional coactivator with PDZ-binding motif (TAZ), myocardin-related transcription factor (MRTF), nuclear factor of activated T-cells (NFAT), nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB), danger-associated molecular patterns (DAMPs), calcineurin (CaN), smooth muscle α-actin (SMA), linker of nucleoskeleton and cytoskeleton (LINC), transcription factors (TF).

References

    1. Kong P., Christia P., Frangogiannis N.G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014;71:549–574. doi: 10.1007/s00018-013-1349-6. - DOI - PMC - PubMed
    1. Gyongyosi M., Winkler J., Ramos I., Do Q.T., Firat H., McDonald K., Gonzalez A., Thum T., Diez J., Jaisser F., et al. Myocardial fibrosis: Biomedical research from bench to bedside. Eur. J. Heart Fail. 2017;19:177–191. doi: 10.1002/ejhf.696. - DOI - PMC - PubMed
    1. Weber G.F., Zawaideh S., Hikita S., Kumar V.A., Cantor H., Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukoc. Biol. 2002;72:752–761. - PubMed
    1. Weber K.T., Pick R., Jalil J.E., Janicki J.S., Carroll E.P. Patterns of myocardial fibrosis. J. Mol. Cell. Cardiol. 1989;21:121–131. doi: 10.1016/0022-2828(89)90778-5. - DOI - PubMed
    1. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 2013;10:15–26. doi: 10.1038/nrcardio.2012.158. - DOI - PubMed